Summary
For Year 2026-27, Nath Bio-Genes (India) reports the following shareholding: Total Promoters at 45.6%, Mutual Fund at 0.01%, Insurance at 0%, Foreign Institutional Investors at 0.22%, Domestic Institutional Investors at 0.01%, and Retail at 54.17%. This breakdown provides a quick snapshot of ownership distribution for Nath Bio-Genes (India) in 2026-27.
Nath Bio-Genes (India) FAQs
As of 04-2026, the promoter shareholding in Nath Bio-Genes (India) stands at 45.6% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Nath Bio-Genes (India) is 0.22% and 0.01% respectively.
The retail shareholding of the Nath Bio-Genes (India) is 54.17%.
Changes in shareholding patterns of Nath Bio-Genes (India) can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Nath Bio-Genes (India) are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Nath Bio-Genes (India) Associated Pages
